Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin
暂无分享,去创建一个
P. Soboslay | R. G. Gantin | M. Banla | P. Voßberg | K. Komlan | C. Köhler | François Korbmacher | Koffi Padjoudoum | Potchoziou Karabou | Tchalim Solim
[1] A. Onapa,et al. Interruption of the transmission of Onchocerca volvulus in the Kashoya-Kitomi focus, western Uganda by long-term ivermectin treatment and elimination of the vector Simulium neavei by larviciding. , 2017, Acta tropica.
[2] S. D. de Vlas,et al. Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal , 2017, Epidemics.
[3] R. Cheke. Factors affecting onchocerciasis transmission: lessons for infection control , 2017, Expert review of anti-infective therapy.
[4] D. Ndiaye,et al. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin , 2016, PLoS neglected tropical diseases.
[5] M. Boussinesq,et al. Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment , 2016, Parasites & Vectors.
[6] S. Bush,et al. Cross-border collaboration for neglected tropical disease efforts—Lessons learned from onchocerciasis control and elimination in the Mano River Union (West Africa) , 2016, Globalization and Health.
[7] D. Boakye,et al. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon , 2016, PLoS neglected tropical diseases.
[8] R. Rao,et al. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis , 2016, Parasites & Vectors.
[9] Robert A. Cheke,et al. Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa , 2016, PLoS neglected tropical diseases.
[10] Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala. , 2016, Releve epidemiologique hebdomadaire.
[11] J. Kazura. More Progress in Eliminating Transmission of Onchocerca volvulus and Wuchereria bancrofti in the Americas: A Portent of Global Eradication , 2015, The American journal of tropical medicine and hygiene.
[12] L. Coffeng,et al. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis , 2015, Parasites & Vectors.
[13] E. Cupp,et al. Elimination of Onchocerciasis from Mexico , 2015, PLoS neglected tropical diseases.
[14] T. Unnasch,et al. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time , 2015, The Lancet.
[15] P. Enyong,et al. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment , 2015, Parasites & Vectors.
[16] D. Boakye,et al. Onchocerciasis Transmission in Ghana: Persistence under Different Control Strategies and the Role of the Simuliid Vectors , 2015, PLoS neglected tropical diseases.
[17] M. Basáñez,et al. Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] A. Kére-Banla,et al. Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study , 2014, PloS one.
[19] M. Basáñez,et al. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections , 2014, Parasites & Vectors.
[20] M. Grillet,et al. Interruption of Onchocerca volvulus transmission in Northern Venezuela , 2013, Parasites & Vectors.
[21] L. Konaté,et al. Proof-of-Principle of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: Final Results of a Study in Mali and Senegal , 2012, PLoS neglected tropical diseases.
[22] P. Soboslay,et al. Chemokines and cytokines in patients with an occult Onchocerca volvulus infection. , 2012, Microbes and infection.
[23] E. Cupp,et al. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy. , 2011, Acta tropica.
[24] L. Konaté,et al. Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal , 2009, PLoS neglected tropical diseases.
[25] B. Boatin. The Onchocerciasis Control Programme in West Africa (OCP) , 2008, Annals of tropical medicine and parasitology.
[26] L. Yaméogo. Special Intervention Zones , 2008, Annals of tropical medicine and parasitology.
[27] U. Amazigo. The African Programme for Onchocerciasis Control (APOC) , 2008, Annals of tropical medicine and parasitology.
[28] D. M. Hamm,et al. Onchocerca volvulus‐specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy , 2007, Clinical and experimental immunology.
[29] B. Thylefors,et al. Towards the elimination of onchocerciasis , 2006, Annals of tropical medicine and parasitology.
[30] María-Gloria Basáñez,et al. River Blindness: A Success Story under Threat? , 2006, PLoS medicine.
[31] J. Oxford,et al. Would you volunteer to be quarantined and infected with influenza virus? , 2005, Expert review of anti-infective therapy.
[32] G. Adeoye,et al. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC) , 2002, Annals of tropical medicine and parasitology.
[33] C. Back,et al. Sibling species distributions of the Simulium damnosum complex in the West African Onchocerciasis Control Programme area during the decade 1984–93, following intensive larviciding since 1974 , 1998, Medical and veterinary entomology.
[34] A. Abiose. Onchocercal eye disease and the impact of Mectizan treatment. , 1998, Annals of tropical medicine and parasitology.
[35] T R Unnasch,et al. Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. , 1995, The Journal of infectious diseases.
[36] D. Boakye,et al. Progress in controlling the reinvasion of windborne vectors into the western area of the Onchocerciasis Control Programme in West Africa. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[37] C. Lévêque,et al. Onchocerciasis control programme in West Africa: Ten years monitoring of fish populations , 1988 .
[38] F. Derouin,et al. DOUBLE-BLIND STUDY OF IVERMECTIN AND DIETHYLCARBAMAZINE IN AFRICAN ONCHOCERCIASIS PATIENTS WITH OCULAR INVOLVEMENT , 1985, The Lancet.
[39] S. Da. Letter: Recruitment to mental handicap. , 1974 .